Showing results (71-80 of 132) with videos related to
Sort By:
Pageof 14
Clinical and Experimental Immunology|July 1, 1982
Imbalance of T cell subpopulations in patients with chronic lymphocytic leukaemia of the B cell typeF Herrmann, A Lochner, H Philippen, et al.Cardiovascular Drugs and Therapy|October 24, 1998
Postcardioplegic myocardial recovery: effects of halothane, nifedipine, HOE 694, and quinacrineA Lochner, S Genade, E Tromp, et al.Molecular and Cellular Biochemistry|October 7, 1992
The effect of ischaemia-reperfusion on [3H]inositol phosphates and ins(1,4,5)P3 levels in cardiac atria and ventricles--a comparative studyR Mouton, S Genade, B Huisamen, et al.Medicare & Medicaid Research Review|April 23, 2014
Multiple chronic conditions among Medicare beneficiaries: state-level variations in prevalence, utilization, and cost, 2011Kimberly A Lochner, Richard A Goodman, Samual Posner, et al.Basic Research in Cardiology|May 1, 1979
Substrate effects on mitochondrial function and tissue lipids in low-flow hypoxia of isolated perfused rat heartsA Lochner, J C Kotzé, W Gevers, et al.Basic Research in Cardiology|September 1, 1978
The hypoxic, low-flow perfused rat heart: characterization as a model of global ischaemiaA de Kock, A Lochner, J C Kotzé, et al.Basic Research in Cardiology|January 1, 1996
Substrate effects on sarcolemmal permeability in the normoxic and hypoxic perfused rat heartA Lochner, A Pentz, K Williams, et al.Circulation|September 1, 1999
Ischemic preconditioning and the beta-adrenergic signal transduction pathwayA Lochner, S Genade, E Tromp, et al.Journal of Molecular and Cellular Cardiology|December 12, 2001
p38 MAPK activation triggers pharmacologically-induced beta-adrenergic preconditioning, but not ischaemic preconditioningE Marais, S Genade, H Strijdom, et al.Life Sciences|April 14, 2009
Dexamethasone-induced cardioprotection: a role for the phosphatase MKP-1?W-J Fan, S Genade, A Genis, et al.Pageof 14